BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37146192)

  • 1. Low-Cost and Reproductible Method to Obtain Mapping of Lymphatic Drainage in Patient with Early Endometrial Cancer.
    Faur FI; Clim IA; Pasca P; Prodan C; Nati I; Dobrescu A; Florea S; Rosu M; Totolici B; Duta C; Lazar G
    Chirurgia (Bucur); 2023 Apr; 118(2):153-160. PubMed ID: 37146192
    [No Abstract]   [Full Text] [Related]  

  • 2. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
    Nagar H; Wietek N; Goodall RJ; Hughes W; Schmidt-Hansen M; Morrison J
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013021. PubMed ID: 34106467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical versus Utero-Ovarian Ligament Injection of the Tracer for the Pelvic Sentinel Lymph Node Mapping in Gynecologic Oncology: A Prospective Observational Study.
    Uccella S; Garzon S; Bosco M; Porcari I; Lanzo G; Laganà AS; Chiantera V; Cliby WA; Mariani A; Franchi M; Zorzato PC
    Gynecol Obstet Invest; 2022; 87(3-4):242-247. PubMed ID: 35584619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
    Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
    Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
    El-Agwany AS; Meleis MH
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.
    Geppert B; Lönnerfors C; Bollino M; Persson J
    Gynecol Oncol; 2018 Mar; 148(3):491-498. PubMed ID: 29273307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Extraordinary Location of Sentinel Lymph Nodes in a Patient with Endometrial Cancer.
    Comba C; Aslan E; Vatankulu B; Tatar Z; Demir AA; Demir O
    J Minim Invasive Gynecol; 2023 Aug; 30(8):613-614. PubMed ID: 37137423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
    Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between laparoscopic and robotic surgery for sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging.
    Chaowawanit W; Campbell V; Wilson E; Chetty N; Perrin L; Jagasia N; Barry S
    J Obstet Gynaecol; 2021 May; 41(4):642-646. PubMed ID: 32812452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer: Comparison of Real-Time Fluorescence With Indocyanine Green and Methylene Blue.
    Buda A; Di Martino G; Vecchione F; Bussi B; Dell'Anna T; Palazzi S; Cantù MG; Marchette MD; Milani R
    Int J Gynecol Cancer; 2015 Oct; 25(8):1513-8. PubMed ID: 26397069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment.
    Kessous R; How J; Abitbol J; Puzhakkal S; Kogan L; Yasmeen A; Salvador S; Gotlieb WH; Lau S
    Int J Gynecol Cancer; 2019 Sep; 29(7):1121-1125. PubMed ID: 31320490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer.
    Rozenholc A; Samouelian V; Warkus T; Gauthier P; Provencher D; Sauthier P; Gauthier F; Drakopoulos P; Cormier B
    Gynecol Oncol; 2019 Jun; 153(3):500-504. PubMed ID: 30902369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of methylene blue dye for sentinel lymph node mapping in early-stage gynecological cancers - An option for low resource settings.
    Singh N; Agrawal S
    J Cancer Res Ther; 2022; 18(4):1088-1092. PubMed ID: 36149165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
    Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
    Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.